Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5NDA

NMR Structural Characterisation of Pharmaceutically Relevant Proteins Obtained Through a Novel Recombinant Production: The Case of The Pulmonary Surfactant Polypeptide C Analogue rSP-C33Leu.

5NDA の概要
エントリーDOI10.2210/pdb5nda/pdb
NMR情報BMRB: 34114
分子名称rSP-C33Leu -RECOMBINANT PULMONARY SURFACTANT-ASSOCIATED POLYPEPTIDE C ANALOGUE- (1 entity in total)
機能のキーワードprotein, pulmonary surfactant protein, sp-c analogue, recombinant protein, solubility tag, fusion protein, nt domain, protein structure
由来する生物種Sus scrofa (Pig)
タンパク質・核酸の鎖数1
化学式量合計3600.73
構造登録者
Venturi, L.,Pioselli, B.,Johansson, J.,Rising, A.,Kronqvist, N.,Nordling, K. (登録日: 2017-03-08, 公開日: 2017-06-07, 最終更新日: 2024-06-19)
主引用文献Kronqvist, N.,Sarr, M.,Lindqvist, A.,Nordling, K.,Otikovs, M.,Venturi, L.,Pioselli, B.,Purhonen, P.,Landreh, M.,Biverstal, H.,Toleikis, Z.,Sjoberg, L.,Robinson, C.V.,Pelizzi, N.,Jornvall, H.,Hebert, H.,Jaudzems, K.,Curstedt, T.,Rising, A.,Johansson, J.
Efficient protein production inspired by how spiders make silk.
Nat Commun, 8:15504-15504, 2017
Cited by
PubMed Abstract: Membrane proteins are targets of most available pharmaceuticals, but they are difficult to produce recombinantly, like many other aggregation-prone proteins. Spiders can produce silk proteins at huge concentrations by sequestering their aggregation-prone regions in micellar structures, where the very soluble N-terminal domain (NT) forms the shell. We hypothesize that fusion to NT could similarly solubilize non-spidroin proteins, and design a charge-reversed mutant (NT*) that is pH insensitive, stabilized and hypersoluble compared to wild-type NT. NT*-transmembrane protein fusions yield up to eight times more of soluble protein in Escherichia coli than fusions with several conventional tags. NT* enables transmembrane peptide purification to homogeneity without chromatography and manufacture of low-cost synthetic lung surfactant that works in an animal model of respiratory disease. NT* also allows efficient expression and purification of non-transmembrane proteins, which are otherwise refractory to recombinant production, and offers a new tool for reluctant proteins in general.
PubMed: 28534479
DOI: 10.1038/ncomms15504
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 5nda
検証レポート(詳細版)ダウンロードをダウンロード

252816

件を2026-04-29に公開中

PDB statisticsPDBj update infoContact PDBjnumon